Hypoxia-induced up-regulation of angiogenin in human malignant melanoma

Cancer Research

Volumn 59, Issue 7, 1999, Pages 1578-1583

  Hartmann, Anke ^a   Kunz, Manfred ^a   Köstlin, Sebastian ^a   Gillitzer, Reinhard ^a   Toksoy, Atiye ^a   Bröcker, Eva B ^a   Klein, C Eberhard ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIN;

ANGIOGENESIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; HYPOXIA; IMMUNOHISTOCHEMISTRY; MELANOMA; METASTASIS; METASTASIS POTENTIAL; PRIORITY JOURNAL; PROTEIN INDUCTION; TUMOR VASCULARIZATION;

ANGIOGENESIS INDUCING AGENTS; CELL HYPOXIA; ENDOTHELIAL GROWTH FACTORS; HUMANS; LYMPHOKINES; MELANOMA; NEOVASCULARIZATION, PATHOLOGIC; NEVUS; PROTEIN BIOSYNTHESIS; PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIBONUCLEASE, PANCREATIC; RNA, MESSENGER; TUMOR CELLS, CULTURED; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0033119037     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Folkman, J., and Klagsbrunn, M. Angiogenic factors. Science (Washington DC), 235: 442-445, 1987.
2. Folkman, J. What is the evidence that tumors are angiogenesis dependent? J. Natl. Cancer Inst., 82: 4-6, 1990.
3. Liotta, L., Kleinerman, J., and Saidel, G. Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary rnetastases following tumor implantation. Cancer Res., 34: 997-1004, 1974.
4. Srivastava, A., Laidler P., Davies, R. P., Morgan, K., and Hughes, L. E. The prognostic significance of tumor vascularity in intermediate-thickness (0.76-4.0 mm thick) skin melanoma: a quantitative histologic study. Am. J. Pathol., 133: 419-423, 1988.
5. Herlyn, M., Clark, W. H., Rodeck, U., Mancianti, M. L., Jambrosic, J., and Koprowski, H. Biology of tumor progression in human melanocytes. Lab. Invest., 56: 461-474, 1987.
6. Ladoux, A., and Frelin, C. Hypoxia is a strong inducer of vascular endothelial growth factor mRNA expression in the heart. Biochem. Biophys. Res. Commun., 195: 1005-1010, 1993.
7. Bouck, N., Stellmach, V., and Hsu, S. C. How tumors become angiogenic. Adv. Cancer Res., 69: 135-174, 1996.
8. Fett, J. W., Strydom, D. J., Lobb, R. R., Alderman, E. M., Bethune, J. L., Riordan, J. F., and Vallee, B. L. Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells. Biochemistry, 24: 5480-5486, 1985.
9. Kurachi, K., Davie, E. W., Strydom, D. J., Riordan, J. F., and Vallee, B. L. Sequence of the cDNA and gene for angiogenin, a human angiogenesis factor. Biochemistry, 24: 5494-5499, 1985.
10. Shapiro, R., Strydom, D. J., Olson, K. A., and Vallee, B. L. Isolation of angiogenin from normal human plasma. Biochemistry, 26: 5141-5146, 1987.
11. Fett, J. W., Bethune, J. L., and Vallee, B. L. Induction of angiogenesis by mixtures of two angiogenic proteins, angiogenin and acidic fibroblast growth factor, in the chicken chorioallantoic membrane. Biochem. Biophys. Res. Commun., 146: 1122-1131, 1987.
12. Riordan, J. F., and Vallee, B. L. Human angiogenin, an organogenic protein. Br. J, Cancer. 57: 587-590, 1988.
13. Jimi, S., Ho, K., Kohno, K., Ono, M., Kuwano, M., Hagaki, Y., and Ishikawa, H. Modulation by bovine angiogenin of tubular morphogenesis and expression of plasminogen activator in bovine endothelial cells. Biochem. Biophys. Res. Commun., 211: 476-483, 1995.
14. Olson, K. A., French, T. C. Vallee, B. L., and Fett, J. W. A monoclonal antibody to human angiogenin suppresses minor growth in athymic mice. Cancer Res., 54: 4576-4579, 1994.
15. Olson, K. A., Fett, J. W., French, T. C., Key, M. E., and Vallee, B. L. Angiogenin antagonists prevent tumor growth in vivo. Proc. Natl. Acad. Sci. USA, 92: 442-446, 1995.
16. Leung, D. W., Cachianes, G., Kuang, W-J., Goeddel, D. V., and Ferrara, N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science (Washington DC), 246: 1306-1309, 1989.
17. Keck, P. J., Hauser, S. D., Krivi, G., Sanzo, K., Warren, T., Feder, J., and Connolly, D. T. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science (Washington DC), 246: 1309-1312, 1989.
18. Connolly, D. T., Heuvelman, D. M., Nelson, R., Olander, J. V., Eppley, B. L., Delfino, J. J., Siegel, N. R., Leimgruber, R. M., and Feder, J. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J. Clin. Invest., 84: 1470-1478, 1989.
19. Takeshita, S., Zheng, L. P., Brogi, E., Kearney, M., Pu, L. Q., Bunting, S., Ferrara, N., Symes, J. F., and Isner, J. M. Therapeutic angiogenesis: a single intra-arterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hindlimb model. J. Clin. Invest., 93: 662-670, 1994.
20. Phillips, H. S., Hains, J., Leung, D. W., and Ferrara, N. Vascular endothelial growth factor is expressed in rat corpus luteum. Endocrinology, 127: 965-967, 1990.
21. Dvorak, H. E., Sioussat, T. M., Brown, L. F., Nagy, J. A., Sotrel, A., Manseau, E., Van De Water, L., and Senger, D. R. Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels. J. Exp. Med., 174: 1275-1278, 1991.
22. Plate, K. H., Breier, G., Weich, H. A., and Risau, W. Vascular endothelial growth factor is a potential tumor angiogenesis factor in human gliomas in vivo. Nature (Lond.), 359: 845-848, 1992.
23. Claffey, K. P., Brown, L. F., del Aguila, L. F., Tognazzi, K., Yeo, K-T., Manseau, E. J., and Dvorak, H. F. Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis. Cancer Res., 56: 172-181, 1996
24. Shweiki, D., Itin, A., Soffer, D., and Keshet, E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature (Lond.), 359: 843-845, 1992.
25. Plate, K. H., Breier, G., Millauer, B., Ullrich, A., and Risau, W. Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis. Cancer Res., 53: 5822-5827, 1993.
26. Plate, K. H., Breier, G., Weich, H. A., Mennel, H. D., and Risau, W. Vascular endothelial growth factor and glioma angiogcnesis: coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms. Int. J. Cancer. 59: 520-529, 1994.
27. Poetgens, A. J. G., Lubsen, N. H., van Altena, M. C., Schoenmakers, J. G. G., Ruiter, D. J., and de Waal, R. M. W. Vascular permeability factor expression influences tumor angiogenesis in human melanoma lines xenografted to nude mice. Am. J. Pathol., 146: 197-209, 1995.
28. Bordoni, R., Fine, R., Murray, D., and Richmond, A. Characterization of the role of melanoma growth stimulatory activity (MGSA) in the growth of normal melanocytes, nevocytes, and malignant melanocytes. J. Cell Biochem., 44: 207-219, 1990.
29. van Muijen, G. N. P., Cornelissen, I. M. H. A., Jansen, C. F. J., and Ruiter, D. J. Progression markers in metastasizing human melanoma cells xenografted to nude mice. Anticanccr Res., 9: 879-884, 1989.
30. van Muijen, G. N. P., Jansen, C. F. J., Cornelissen, L. M. H. A., Beck, J. L. M., and Ruiter, D. J. Establishment and characterization of a human melanoma cell line (MV3) which is highly metastatic in nude mice. Int. J. Cancer, 48: 85-91, 1991.
31. Weidner, N., Semple, J. P., Welch, W. R., and Folkman, J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N. Engl. J. Med., 324: 1-8, 1991.
32. Bamhill, R. L., Fandrey, K., Levy, M. A., Mihm, M. C., and Hyman, B. Angiogenesis and tumor progression of melanoma. Quantification of vascularity in melanocytic nevi and cutaneous malignant melanoma. Lab. Invest., 67, 331-337, 1992.
33. Badet, J., Soncin, F., Guitton, J-D., Lamare, O., Cartwright, T., and Barritault, D. Specific binding of angiogenin to calf pulmonary artery endothelial cells. Proc. Natl. Acad. Sci. USA. 86: 8427-8431, 1989.
34. Bicknell, R., and Vallee, B. L. Angiogenin activates endothelial cell phospholipase C. Proc. Natl. Acad. Sci. USA, 85: 5961-5965, 1988.
35. Soncin, F., Shapiro, R., and Fett, J. W. A cell-surface proteoglycan mediates human adenocarcinoma HT-29 cell adhesion to human angiogenin. J. Biol. Chem., 269: 8999-9005, 1994.
36. Hu, G-F., Strydom, D. J., Fett, J. W., Riordan, J. F., and Vallee, B. L. Actin is a binding protein for angiogenin. Proc. Natl. Acad. Sci. USA, 90: 1217-1221, 1993.
37. Hu, G-F., Riordan, J. F., and Vallee, B. E. Angiogenin promotes invasiveness of cultured endothelial cells by stimulation of cell-associated proteolytic activities. Proc. Natl. Acad. Sci. USA, 91: 12096-12100, 1994.
38. Weiner, H. L., Weiner, L. H., and Swain, J. L. Tissue distribution and developmental expression of the messenger RNA encoding angiogenin. Science (Washington DC), 237, 280-282, 1997.
39. Helmlinger, G., Yuan, F., Dellian, M., and Jain, R. K. Interstitial pH and pO2 gradients in solid tumors in vivo: high resolution measurements reveal lack of correlation. Nat. Med., 3: 177-182, 1997.
40. Forsythe, J. A., Jiang, B. H., Iyer, N. V., Agani, F., Leung, S. W., Koos, R. D., and Semenza, G. L. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell. Biol., 16: 4604-4613, 1996.
41. Rupee, R. A., and Baeuerle, P. A. The genomic response of tumor cells to hypoxia and reoxygenation. Differential activation of transcription factors AP-1 and NF-κB. Eur. J. Biochem., 234: 632-640, 1995.